DB09379ApprovedWithdrawnProtein Based Therapies
Sutilain is a member of the keratase family which includes agents such as papain. It is able to dissolve the intercellular matrix which helps with desquamation. Sutilain contains proteolytic enzymes... Sutilain contains proteolytic enzymes derived from Bacillus subtilis and it is available as a cream-colored odorless powder.
- Mechanism
- Curator reviewed · 1 reference
Sutilain is a proteolytic enzyme that dissolves necrotic tissue and hyaluronidase.
- Primary indication
- Sutilain was indicated, in the form of an ointment, as a biochemical debridement of second and third-degree burns, incisional traumatic and pyrogenic wounds and ulcers occurring due to peripheral vascular diseases.Curator reviewed · 1 structured indication
- First approval
- Canada, 1987
- Also known as
- Sutilains
- Code names
- BAX-1515
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of January 17, 2025
Which other approved drugs treat the same conditions as Sutilain, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account